Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Eur J Trauma Emerg Surg ; 44(6): 859-867, 2018 Dec.
Article in English | MEDLINE | ID: mdl-28965136

ABSTRACT

INTRODUCTION: The wound healing properties of platelet-rich plasma (PRP) gel have been documented in many studies. PRP gel has also become a promising agent for treating surgical site infections. In this study, we investigated the antibacterial activity and wound healing effectiveness of PRP in an animal model of Methicillin-resistant Staphylococcus aureus subsp. aureus (MRSA N315)-contaminated superficial soft tissue wounds. MATERIALS AND METHODS: Subcutaneous wounds in Wistar Albino male rats were created by making two cm midline incisions followed by inoculation of microorganisms. Study groups comprised of Sham (no treatment), PRP alone, MRSA alone, MRSA + PRP, MRSA + Vancomycin, and MRSA + Vancomycin + PRP groups. We inoculated 0.1 mL (3 × 108 CFU/mL) of MRSA in contaminated groups. After 8 days, all rats were killed, wounds were excised and subjected to histopathologic examination, and MRSA counts were determined. RESULTS: MRSA counts in MRSA, MRSA + PRP, MRSA + Vancomycin and MRSA + Vancomycin + PRP groups were 5.1 × 106 (SD ± 0.4) CFU/mL, 4.3 × 106 (SD ± 0.7) CFU/mL, 2.3 × 106 (SD ± 0.3) CFU/mL, 1.1 × 106 (SD ± 0.4) CFU/mL, respectively. The inflammation scores of MRSA + PRP, MRSA + Vancomycin, and MRSA + Vancomycin + PRP groups were significantly lower than the MRSA group. MRSA + Vancomycin + PRP group inflammation score was significantly lower than the MRSA + PRP group. DISCUSSION: All treatment groups were effective in wound healing and decreasing the MRSA counts. MRSA + PRP combined created identical inflammation scores to the PRP group. More in vivo studies are required to corroborate these findings.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Methicillin-Resistant Staphylococcus aureus , Platelet-Rich Plasma , Staphylococcal Infections/drug therapy , Surgical Wound Infection/drug therapy , Vancomycin/therapeutic use , Animals , Anti-Bacterial Agents/administration & dosage , Disease Models, Animal , Gels , Male , Rats , Rats, Wistar , Vancomycin/administration & dosage
2.
Eur J Trauma Emerg Surg ; 43(5): 605-609, 2017 Oct.
Article in English | MEDLINE | ID: mdl-26501196

ABSTRACT

INTRODUCTION: We aimed to define an ideal range of windlass turn degrees for 100 % success rates within the study population. METHODS: CAT was applied at mid-thigh level. Data included age, lower extremity circumference (LEC), body mass index (BMI), and mean arterial pressure (MAP). Windlass turn degrees were measured in failed and successful participants. The failed participants' windlass mechanisms were twisted until the popliteal artery was occluded. Failure to success and additional turn degrees to secure the windlass mechanism of CAT was determined. Doppler ultrasound was used to examine the popliteal artery blood flow. RESULTS: 145 servicemen have participated in the study. Initially, 70 % successfully applied CAT. There was no statistically significant difference in BMI and MAP values between successful and failed participants. The mean LEC for failed and successful applications were 57.5 ± 4 and 56.8 ± 4, respectively. The required turn degrees for success ranged between 45° and 270°. After correction, the cumulative success rate of 93 and 100 % was reached at 990° and 1170° overall turn degrees. DISCUSSION: In order to adequately stop limb hemorrhage, soldiers should be taught their optimal turn degrees.


Subject(s)
Hemorrhage/prevention & control , Lower Extremity/injuries , Military Personnel , Tourniquets , Warfare , Adult , Equipment Design , Female , Hemorrhage/etiology , Hemorrhage/physiopathology , Humans , Lower Extremity/blood supply , Male , Popliteal Artery/physiopathology , Prospective Studies , Pulsatile Flow , Treatment Outcome , Wounds and Injuries/complications
3.
Transpl Infect Dis ; 18(1): 55-62, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26565663

ABSTRACT

AIM: The aim of this study was to determine the effects of hepatitis B surface antigen (HBsAg) positivity of the donors on graft survival and liver complications in HBsAg(+) renal transplant recipients. PATIENTS AND METHOD: A group of 55 patients who underwent renal transplantation (RTx) in our hospital between 2001 and 2012 were included in the study. Patients were divided into 2 groups. Group 1 (n = 50) consisted of HBsAg(+) renal transplant recipients (RTR) whose donors were HBsAg(-). In Group 2 (n = 5), RTR and donors were both HBsAg(+). Lymphocyte cross matches, number of mismatches, donor types, renal replacement treatment modalities, drugs of induction treatment, and preoperative hepatitis B virus DNA titers of the groups were similar. In Group 1, 42 patients were taking lamivudine, 3 patients were taking entecavir, and 5 patients were taking tenofovir. All of the patients in Group 2 were taking lamivudine. Patient and graft survival rates, graft functions, acute hepatitis rates, acute rejection rates, and other clinical outcomes of the groups were compared. RESULTS: Demographic data of the groups were similar. Acute rejection rates (P = 0.458), graft survival rates (P = 0.515), and patient survival rates (P = 0.803) were also similar. No significant difference was found between the groups in terms of acute hepatitis rate (P = 0.511), glomerular filtration rate (calculated by Modification of Diet in Renal Disease formula) in the last follow-up (P = 0.988), alanine aminotransferase levels (P = 0.069), or delayed graft function rate (P = 0.973). Rates of chronic allograft dysfunction and new onset diabetes mellitus after transplantation were similar. CONCLUSION: Our study revealed that, RTx from HBsAg(+) donors to HBsAg(+) recipients is safe with antiviral treatment.


Subject(s)
Hepatitis B Surface Antigens/immunology , Hepatitis B virus/immunology , Hepatitis B/virology , Kidney Transplantation/adverse effects , Postoperative Complications/prevention & control , Adult , Antiviral Agents/administration & dosage , Female , Glomerular Filtration Rate , Graft Rejection , Graft Survival , Guanine/administration & dosage , Guanine/analogs & derivatives , Humans , Lamivudine/administration & dosage , Liver/virology , Male , Middle Aged , Postoperative Complications/virology , Tenofovir/administration & dosage , Tissue Donors , Transplant Recipients
4.
Eur J Trauma Emerg Surg ; 41(2): 149-55, 2015 Apr.
Article in English | MEDLINE | ID: mdl-26038258

ABSTRACT

INTRODUCTION: In recent military conflicts, military surgeons encounter more high-energy injuries associated with explosives. Advances in the field care and shorter evacuation time increased survival. However, casualties still incur severe injuries especially to the extremities. We present wound patterns, anatomical distribution and severity of injuries in a Role 2 hospital. MATERIALS AND METHODS: Two years data have been retrospectively reviewed. Only explosives and firearms injuries were included in the study. Patient profile, admission details, mechanism of injury, AIS anatomical locations, ISS, surgical and medical treatments have been analyzed. RESULTS: Data revealed 170 male casualties. IEDs and GSW accounted for 133 (78%) and 37 (22%) casualties, respectively. An average of 1.8 IED and 1.2 GSW anatomical locations were exposed to injuries. Regardless of the mechanism, injuries were most commonly located in the extremities. IEDs caused significantly higher soft tissue injuries. DISCUSSION: Explosives do not necessarily cause more severe injuries than firearms. However, fragments create multiple, complicated soft tissue injuries which constitute more than half of the injuries. Timely wound debridement and excision of contaminated tissue are crucial to manage extremity soft tissue injuries. CONCLUSION: Casualty care should be assessed within the context of the capabilities present at a hospital and the cause, type and severity of the wounds. The NATO description of Role 2 care only requires an integrated surgical team for damage control surgery with limited diagnostic and infrastructural capabilities.


Subject(s)
Blast Injuries/therapy , Critical Care/organization & administration , Hospitals, Military/statistics & numerical data , Military Medicine/organization & administration , Soft Tissue Injuries/therapy , War-Related Injuries/therapy , Wounds, Penetrating/therapy , Adolescent , Adult , Blast Injuries/mortality , Critical Care/statistics & numerical data , Health Resources , Humans , Iraq War, 2003-2011 , Male , Middle Aged , Military Personnel/statistics & numerical data , Patient Admission/statistics & numerical data , Patient Care Team/organization & administration , Retrospective Studies , Soft Tissue Injuries/mortality , Trauma Severity Indices , Turkey/epidemiology , War-Related Injuries/mortality , Wounds, Penetrating/mortality
5.
J R Army Med Corps ; 161(4): 332-5, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25388480

ABSTRACT

INTRODUCTION: Haemorrhage from the injured extremity is a significant cause of preventable death in military settings. This study evaluated the effect of training on the efficacy of the combat application tourniquet (CAT) and to define standards for military personnel. METHOD: Participants from a training tank battalion were randomised. Data collected included age, body mass index, mean arterial pressure, hand dominance, femoral artery diameter and skin thickness. The study involved tourniquet application times (AT) and application success rates in basic, after-training and eyes-closed phases. Doppler ultrasound was used to identify the presence or absence of popliteal, radial and ulnar artery pulses. RESULTS: A total of 102 trainees participated. In the after-training phase, the left and right upper extremity ATs were 35 ± 13.1 s, and 34.8 ± 13.5 s and the right and left lower extremity ATs were 20.6 ± 6.0 s and 20.5 ± 5.5 s, respectively. The overall tourniquet success rates in three successive study phases were 69.6%, 82.4% and 91.2%, respectively. A negative significant relationship was found between extremity circumference and tourniquet success. DISCUSSION: The results show that the efficacy of CAT application increases with training. Further studies are required to investigate the reasons underlying application failures. This single group prospective randomised study involves level of evidence 4.


Subject(s)
Hemorrhage/prevention & control , Military Medicine/education , Military Personnel , Self Care , Simulation Training , Tourniquets , Adult , Curriculum , Hemorrhage/etiology , Humans , Lower Extremity , Male , Prospective Studies , Time Factors , Upper Extremity , War-Related Injuries/complications , War-Related Injuries/therapy , Young Adult
6.
Transplant Proc ; 45(3): 887-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23622579

ABSTRACT

OBJECTIVES: Renal transplantation (RT) is the most appropriate form of treatment for end-stage renal disease (ESRD). Pre-emptive RT decreases the rates of delayed graft function and acute rejection episodes, increasing patient and graft survival, while reducing costs and complications associated with dialysis. In this study, we investigated the relationship between a predialysis education program (PDEP) for patients and their relatives and pre-emptive RT. METHODS: We divided 88 live donor kidney transplant recipients into 2 groups: transplantation without education (non-PDEP group; n = 27), and enrollment in an education program before RT (PDEP group n = 61). RESULTS: Five patients in the non-PDEP group underwent pre-emptive transplantation, versus 26 of the PDEP group. The rate of pre-emptive transplantations was significantly higher among the educated (42.62%) versus the noneducated group (18.51%; P < .001). CONCLUSION: PDEP increased the number of pre-emptive kidney transplantations among ESRD patients.


Subject(s)
Kidney Transplantation/statistics & numerical data , Patient Education as Topic , Renal Dialysis , Adult , Female , Humans , Male
7.
Transplant Proc ; 40(10): 3755-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19100482

ABSTRACT

A 28-year-old woman was admitted with a sudden loss of vision in the right eye. She underwent renal transplantation in June 1999 for chronic renal failure secondary to amyloidosis. Upon ophthalmologic examination, the patient was diagnosed with central retinal vein occlusion. Physical and laboratory examinations failed to disclose any remarkable pathology except for high homocysteine levels. Hyperhomocysteinemia has been reported as a potential risk factor requiring treatment and a significant association has been found between this condition and central retinal vein thrombosis.


Subject(s)
Hyperhomocysteinemia/complications , Kidney Transplantation , Retinal Vein Occlusion/etiology , Adult , Amyloidosis/complications , Diabetic Retinopathy/complications , Female , Fluorescein Angiography , Humans , Intraocular Pressure , Kidney Failure, Chronic/etiology , Kidney Failure, Chronic/surgery , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/physiopathology , Risk Factors
8.
Oral Dis ; 12(6): 553-8, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17054767

ABSTRACT

OBJECTIVE: The aim of this study was to determine the prevalence of oral lesions in 13- to 16-year-old students. METHODS: A cross-sectional survey was carried out on students in Duzce, a province in the western Black Sea region of Turkey. A total of 993 children aged between 13 and 16 from eight secondary schools were examined. Oral lesions with recurrent behavior, if observed, were recorded at the time of examination. Venous blood samples were obtained for detecting hemoglobin levels. RESULTS: Two hundred sixty adolescents (26.2%) were diagnosed with at least one oral mucosal lesion at the time of the examination. Thirteen different mucosal alterations were diagnosed, and the most common lesions were angular cheilitis (9%), linea alba (5.3%), and aphthous ulceration (3.6%). The correlation between occurrence of mucosal lesions and sex was not statistically significant (P > 0.05). Statistical evaluation of the data revealed a significant relationship only between the presence of angular cheilitis and anemia (P < 0.05). CONCLUSION: This study is the first epidemiologic study of oral mucosal lesions in adolescents in Turkey. Angular cheilitis was the only oral mucosal lesion that had a significant correlation with anemia.


Subject(s)
Cheilitis/epidemiology , Stomatitis, Aphthous/epidemiology , Adolescent , Anemia/complications , Cheilitis/blood , Cheilitis/etiology , Chi-Square Distribution , Cross-Sectional Studies , Female , Herpes Labialis/epidemiology , Humans , Male , Mouth Mucosa/pathology , Prevalence , Sex Factors , Tongue, Fissured/epidemiology , Turkey/epidemiology
9.
J Hand Surg Br ; 31(4): 413-5, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16690181

ABSTRACT

Sarcoidosis is a multisystemic granulomatous disease. In the case presented, autoamputation of the distal phalanx of a little finger of the left hand was observed. The possibility of autodigital amputation as a result of sarcoidosis is discussed.


Subject(s)
Amputation, Surgical , Finger Injuries/etiology , Sarcoidosis/complications , Sarcoidosis/psychology , Self-Injurious Behavior , Adult , Female , Humans , Sarcoidosis, Pulmonary/psychology , Skin Diseases/psychology
10.
Int J Clin Pract ; 58(5): 432-5, 2004 May.
Article in English | MEDLINE | ID: mdl-15206496

ABSTRACT

The benefits of angiotensin-converting enzyme inhibitors and angiotensin II (ATII) receptor antagonist therapy of diabetic nephropathy (DNP) are thought to be largely the result of attenuation of ATII effects on proteinuria. The aim of the study was to ascertain whether there is the additive anti-proteinuric effect of enalapril plus losartan in DNP. Twenty-two patients with DNP were studied. Patients were randomly assigned to enalapril 10 mg/day (11 patients) or losartan 50 mg/day (11 patients) administered in a single oral dose in the morning for 12 weeks. and then, in 10 patients (five patients from enalapril group and five patients from losartan group), combination therapy (10 mg/day enalapril and 50 mg/day losartan) was started and continued for 12 weeks. In 12 patients, initial drugs dosages were doubled (six patients 20 mg/day enalapril and six patients 100 mg/day losartan), and monotherapy was continued for 12 weeks. Blood pressure and proteinuria were measured before and after therapy. Adverse effects were recorded at every visit. Proteinuria decreased by 33% with enalapril and losartan administered alone (p < 0.05). Co-administration of enalapril and losartan decreased proteinuria by a greater extent compared with enalapril and losartan administered alone (51%, p<0.05). This proteinuria level was significantly lower than the proteinuria level of 12 weeks therapy with enalapril and losartan alone. The decrease of proteinuria was 37% in double-dose monotherapy group (p < 0.05). Reduction of mean arterial blood pressure (MAP) in co-administration of enalapril and losartan was higher than enalapril and losartan administered alone (p < 0.05). Combination of enalapril and losartan decreased proteinuria and MAP by a greater extent compared with enalapril and losartan administered alone. We have found that proteinuria reduction induced by combined therapy is maintained throughout short-term follow-up; a greater anti-proteinuric response was observed in the patients with DNP.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Diabetes Mellitus, Type 2/drug therapy , Diabetic Nephropathies/drug therapy , Enalapril/therapeutic use , Losartan/therapeutic use , Proteinuria/drug therapy , Adult , Aged , Drug Therapy, Combination , Female , Humans , Male , Middle Aged
11.
Transplant Proc ; 36(1): 41-3, 2004.
Article in English | MEDLINE | ID: mdl-15013295

ABSTRACT

Iron deficiency is an important factor in the management of anemia in both dialysis and transplant patients. Serum ferritin and transferrin saturation (TS) may be influenced by the presence of inflammation. Recently, the soluble transferrin receptor (s-TfR) has been considered to be a marker of functional iron stores. In this study, parameters of the iron state were investigated in terms of agreement (assessed by kappa) with the diagnosis of iron deficiency and with inflammation. The study was performed in 38 hemodialysis, 31 continuous ambulatory peritoneal dialysis, and 21 anemic renal transplant patients. CRP and amyloid A protein (AAP) were studied as markers of inflammation. Iron deficiency was defined as ferritin <100 mg/L, TS <20%, or s-TfR >1.76 mg/mL. We observed that s-TfR levels were significantly related to both dialysis duration (r = 0.28 in dialysis and r = 0.60 in transplant patients, both P <.05) and PTH levels (r = 0.23 in dialysis and r = 0.55 in transplant patients, both P <.05). Among the transplant group, ferritin and TS, as well as TS and s-TfR were significantly related (r = 0.84 and r = -0.64, respectively), but not s-TfR and ferritin. Among the dialysis group, ferritin and TS, and also TS and s-TfR, were significantly related (r = 0.35 and r = -0.30, respectively), whereas s-TfR and ferritin were not. In the transplant group, the kappa value for agreement between ferritin and TS in the diagnosis of iron deficiency was 0.76 (P =.006), and 0.33 (P =.04), respectively. Among patients with CRP levels <0.3 mg/L or AAP levels <6.4 mg/L, the relation between parameters of iron state was more robust. The kappa value for agreement between ferritin and s-TfR was 0.49 (P =.006) in the dialysis group and 1 (P =.002) for that between ferritin and TS in the transplant group. Our results suggest that PTH levels may influence s-TfR levels. Discordance between ferritin, TS, and s-TfR as markers of iron deficiency might be explained by the effects of inflammation.


Subject(s)
Inflammation/physiopathology , Iron Deficiencies , Renal Replacement Therapy/adverse effects , Adult , Anemia/etiology , Biomarkers/blood , Female , Ferritins/blood , Humans , Iron/metabolism , Kidney Transplantation , Male , Peritoneal Dialysis, Continuous Ambulatory , Postoperative Complications/blood , Serum Amyloid A Protein/analysis
12.
Transplant Proc ; 36(1): 99-101, 2004.
Article in English | MEDLINE | ID: mdl-15013312

ABSTRACT

Management of renal transplant patients requires periodic measurement of renal function, which is usually assessed by measuring the glomerular filtration rate (GFR). The most commonly used marker for GFR is serum creatinine, although muscle wasting and tubular secretion may lead to overestimation of the actual GFR. Serum concentrations of the low-molecular-weight proteins, cystatin C and beta(2)-microglobulin (B(2)M), may afford useful markers to determine a reduced GFR. We investigated whether these molecules provide reliable indicators of renal function in 75 renal transplant patients. Cystatin C and B(2)M correlated significantly with creatinine (r =.648, P <.05 and r =.578, P <.05, respectively). Inverse serum creatinine was superior to inverse cystatin C and inverse B(2)M when renal function equations were used (r =.95, P <.05, according to MDRD; r =.87, P <.05, according to Cockroft-Gault). Receiver operating characteristic (ROC) analysis was performed to quantitate the accuracy of the different markers to detect reduced GFR using a cutoff value of 70 mL/min. No significant difference between the areas under the ROC curves comparing cystatin C and B(2)M was observed; however, serum creatinine demonstrated a significantly greater value than cystatin C (.981 vs.724, P =.001). We conclude that serum creatinine is a more efficacious marker than serum cystatin C to assess renal function.


Subject(s)
Cystatins/blood , Glomerular Filtration Rate/physiology , Kidney Transplantation/physiology , Adult , Biomarkers/blood , Creatinine/blood , Creatinine/metabolism , Cystatin C , Humans , ROC Curve , Reproducibility of Results , Statistics, Nonparametric
13.
Transplant Proc ; 36(1): 120-1, 2004.
Article in English | MEDLINE | ID: mdl-15013319

ABSTRACT

Noncompliance with regard to diet, medications and routine physician visits is frequently observed among some patient groups. This results in late graft dysfunction and behavior loss. In the present study, we defined compliance as attendance at 80% or more outpatient visits. The study included 63 cadaveric and 158 living-related renal transplant recipients namely, 150 men and 76 women of 8 to 70 years of age (median 38 +/- 12) who were operated between 1986 and 2001. Demographic data, number of visits attended per month, cigarette smoking, and alcohol intake were probed with a questionnaire that was delivered to the patients, 8 of whom died; hemophagocytic syndrome (n = 4), cardiovascular disease (n = 2), Kaposi' sarcoma (n = 1), and cerebrovascular bleeding (n = 1). Twenty-three patients had lost their graft. Compliance among men was lower than among women, a result that trended toward statistical significance (P =.087). Compliance was not related to marital status (P =.297), but tended to increase with educational background (P =.059). Graft loss (P =.546) and aging (P =.509) were not related to compliance. There was no relationship between compliance and mortality rate (P =.526). Interestingly, living-related kidney transplant recipients showed lower compliance than cadaveric kidney recipients, a result that was statistically significant (P =.04). Noncompliance was also related to cigarette smoking during the pre- and posttransplant periods (P =.008 and P =.03, respectively), as well as alcohol intake (P =.000). In conclusion, male gender and living-related donation are related to noncompliance, but (in contrast with literature) not young age, graft loss, or mortality. Compliance increases with educational status of the patients. Smoking and alcohol intake are closely related to noncompliance.


Subject(s)
Kidney Transplantation/physiology , Kidney Transplantation/psychology , Patient Compliance , Adolescent , Adult , Aged , Alcohol Drinking/epidemiology , Child , Diet , Female , Humans , Male , Marital Status , Middle Aged , Smoking/epidemiology , Treatment Refusal
14.
Transplant Proc ; 36(1): 175-7, 2004.
Article in English | MEDLINE | ID: mdl-15013338

ABSTRACT

In this study we investigated the influence of a tacrolimus (TAC) plus mycophenolate mofetil (MMF) immunosuppressive regimen on the acute rejection rate and side effect profile in renal transplant recipients. The study included 80 living-related and 40 cadaveric donor renal transplant recipients (82 men, 38 women) of mean age 35 +/- 10 years (range, 16 to 58) who were operated between August 1999 and September 2002. The mean HLA mismatches was 3 +/- 1 (range, 0 to 5). All patients received prednisolone, MMF (2 g/d for the first 14 days posttransplant and then 1 g/d) plus TAC (0.2 mg/kg/d). They were followed for the development of rejection attacks and side effects. Diabetes mellitus developed in 13 patients (9 men, 4 women; 10.8%). Initially, patients required insulin therapy but after 6 months, 5 recipients no longer needed insulin therapy and were switched to oral hypoglycermic agents and diet control. Hypertension was diagnosed in 58 patients (48.3%). Neither gender nor donor origin (P =.14; P =.79, respectively) produced a significant difference in diabetes mellitus development. Biopsy proven acute rejection episodes were observed in 16 out of 120 patients (13.3%). Six out of 120 patients lost their grafts throughout the study period including one death because of suicide, one because of cytomegalovirus disease and hemophagocytic syndrome, one due to posttransplant lymphoproliferative disease and two to a cardiac arrhythmia. Only one patient lost his graft due to acute accelerated vascular rejection. Biopsy-proven chronic rejection appeared in one patient. In conclusion, although the incidence of insulin-dependent diabetes mellitus during posttransplant 6 months, seems high it decreased to 1.6% upon reduction of the TAC dosage. TAC plus MMF immunosuppression seems effective and safe in terms of acute rejection rates and side effect profiles.


Subject(s)
Diabetes Mellitus/epidemiology , Graft Rejection/epidemiology , Kidney Transplantation/immunology , Mycophenolic Acid/analogs & derivatives , Mycophenolic Acid/therapeutic use , Tacrolimus/therapeutic use , Administration, Oral , Adolescent , Adult , Cadaver , Diabetes Mellitus/chemically induced , Diabetes Mellitus/drug therapy , Drug Therapy, Combination , Female , Graft Rejection/prevention & control , Histocompatibility Testing , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/physiology , Living Donors , Male , Middle Aged , Tacrolimus/adverse effects , Tissue Donors
15.
Panminerva Med ; 45(1): 59-62, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12682621

ABSTRACT

AIM: In some of the patients undergoing haemodialysis, (HD) resistance might develop against recombinant human erythropoietin (rHuEPO) used for treatment of anaemia. Recently, angiotensin-converting enzyme (ACE) inhibitors that are used to treat hypertension and congestive heart failure in HD patients have been suggested to contribute to anaemia as well by inhibiting erythropoiesis. Our purpose in this study is to investigate whether or not losartan, an angiotensin II (ATII) receptor antagonist, is causing rHuEPO resistance. METHODS: In this prospective study of 12 months, we compared the effects of high dose losartan (100 mg/day) and amlodipine (10 mg/day) on rHuEPO requirement in 40 hypertensive patients receiving rHuEPO for more than 12 months on maintenance HD. Twenty normotensive rHuEPO dependent patients served as control group. Iron deficiency, hyperparathyroidism, aluminium intoxication, infections and inflammations were excluded in all patients. RESULTS: The mean haemoglobin level was found >8 g/dl in all groups. The mean weekly rHuEPO dose increased in the losartan group (p<0.0001 vs before) and remained constant in the other groups. No significant differences were found with PTH, iron status, aetiologies of renal failure in all groups. CONCLUSION: High-dose losartan increases rHuEPO requirement and should be reserved for dialysis patients with hypertension uncontrollable with other antihypertensive medications.


Subject(s)
Anemia/drug therapy , Anemia/etiology , Erythropoietin/therapeutic use , Kidney Failure, Chronic/therapy , Losartan/administration & dosage , Losartan/adverse effects , Renal Dialysis/adverse effects , Adult , Amlodipine/therapeutic use , Angiotensin Receptor Antagonists , Antihypertensive Agents/therapeutic use , Dose-Response Relationship, Drug , Drug Resistance , Female , Humans , Hypertension/complications , Hypertension/drug therapy , Kidney Failure, Chronic/complications , Male , Middle Aged , Prospective Studies , Recombinant Proteins
16.
Int J Clin Pract ; 56(5): 342-4, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12137441

ABSTRACT

AA amyloidosis is a relatively rare disease which complicates chronic inflammatory diseases, chronic infections, familial Mediterranean fever (FMF) and malignant diseases. Although amyloid deposition may be found in many organs, renal involvement dominates the clinical picture. We reviewed 63 patients with AA amyloidosis who presented to our nephrology department between 1995 and 2000. Prognostic markers, detailed history, physical examination and laboratory tests were evaluated. The causes of AA amyloidosis were as follows: FMF 42 (66.6%), pulmonary tuberculosis 9 (14.2%), chronic osteomyelitis 4 (6.3%), bronchiectasia 4 (6.3%), rheumatoid arthritis 1 (1.5%), juvenile idiopathic arthritis 1 (1.5%), inflammatory abdominal aortic aneurysm 1 (1.5 %), unknown aetiology 1 (1.5%). The diagnosis was made on renal biopsies in 63.4% of the patients, while the remaining 36.6% were diagnosed as a result of rectal biopsies. Sixteen patients died. A low serum albumin, high creatinine and high 24-hour urine albumin excretion were associated with high mortality.


Subject(s)
Amyloidosis/complications , Kidney Diseases/etiology , Serum Amyloid A Protein , Adolescent , Adult , Amyloidosis/diagnosis , Amyloidosis/therapy , Biomarkers/blood , Biopsy/methods , Chronic Disease , Female , Humans , Kidney Diseases/diagnosis , Kidney Diseases/therapy , Male , Middle Aged , Prognosis , Renal Dialysis
17.
Int J Clin Pract ; 56(4): 310-1, 2002 May.
Article in English | MEDLINE | ID: mdl-12074217

ABSTRACT

There is no routine test to evaluate the activity of Behçet's disease (BD). Ferritin as a serum predictor of iron storage is an important acute phase reactant. In this study, we assessed serum ferritin levels in patients with active BD and compared them with those of patients with inactive BD. We aimed to show the relationship between ferritin and BD. The patients with BD were subdivided into two groups according to disease activity: active (24 patients; 18 men and 6 women, average age 36.5 +/- 4.9 [28-45] years), and inactive (20 patients; 16 men and 4 women, average age 37.2 +/- 5.2 [30-49] years). Twenty healthy volunteers (15 men and 5 women; average age 38.2 +/- 4.6 [30-47] years) served as controls. Patients with active BD had significantly higher serum ferritin levels (p=0.0001) than the inactive and control groups. Ferritin levels in patients with inactive BD did not differ significantly from healthy control subjects (p=0.687). We concluded that in patients with active BD, serum ferritin levels are increased and do not reflect serum iron levels.


Subject(s)
Behcet Syndrome/blood , Ferritins/blood , Acute Disease , Adult , Biomarkers/blood , Case-Control Studies , Female , Humans , Male , Middle Aged , Statistics, Nonparametric
18.
J Int Med Res ; 30(1): 80-4, 2002.
Article in English | MEDLINE | ID: mdl-11921503

ABSTRACT

The thyroid functions of 42 subjects with bipolar affective disorder receiving regular lithium therapy were analysed and their thyroid glands were examined by ultrasonography. Following the receipt of lithium therapy (duration 4-156 months), three subjects displayed subclinical hypothyroidism (7.1%), three subclinical hyperthyroidism (7.1%) and one hyperthyroidism (2.4%). Moreover, goitre was detected in 16 (38.1%) subjects. An increase in the conversion of free thyroxine (T4) to free tri-iodothyrosine (T3), which is an indication of mild thyroid dysfunction, was identified in 20 (47.6%) subjects, and was mostly seen in male subjects under 40 years of age and in those having weight gain. In conclusion, some thyroid dysfunctions were observed in the patients treated with lithium.


Subject(s)
Antimanic Agents/adverse effects , Bipolar Disorder/drug therapy , Lithium/adverse effects , Thyroid Diseases/chemically induced , Adolescent , Adult , Bipolar Disorder/blood , Female , Goiter/blood , Goiter/chemically induced , Humans , Hyperthyroidism/blood , Hyperthyroidism/chemically induced , Hypothyroidism/blood , Hypothyroidism/chemically induced , Male , Middle Aged , Thyroid Diseases/blood , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
20.
J Dermatol ; 28(3): 158-60, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11349468

ABSTRACT

Alkaptonuria is a rare, autosomally recessive, metabolic disorder caused by a deficiency in homogentisic acid oxidase. It results in accumulation and deposition of homogentisic acid in cartilage, eyelids, forehead, cheeks, axillae, genital regions, nail beds, buccal mucosa, larynx, tympanic eardrum, and the tendons. We report a 33-year-old woman who presented with alkaptonuria and ochronotic pigment deposited in articular cartilage and cartilage of the ear and sclera.


Subject(s)
Alkaptonuria/diagnosis , Calcinosis/diagnosis , Spinal Diseases/diagnosis , Adult , Alkaptonuria/pathology , Calcinosis/diagnostic imaging , Diagnosis, Differential , Ear Cartilage , Female , Humans , Ochronosis/diagnosis , Ochronosis/pathology , Radiography , Spinal Diseases/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...